Eris Lifesciences Ltd (BOM:540596)
₹ 1353.8 11.3 (0.84%) Market Cap: 184.29 Bil Enterprise Value: 213.23 Bil PE Ratio: 52.93 PB Ratio: 6.65 GF Score: 93/100

Q3 2024 Eris Lifesciences Ltd Earnings Call Transcript

Feb 13, 2024 / 11:00AM GMT
Release Date Price: ₹923.55 (+1.07%)
Operator

Ladies and gentlemen, good day, and welcome to the Q3 FY '24 Earnings Conference Call of Eris Lifesciences Limited. We have with us on the call today Mr. Amit Bakshi, Chairman and Managing Director; and Mr. V. Krishnakumar, Chief Operating Officer and Executive Director. (Operator Instructions) Please note that this call is being recorded.

I now hand the conference over to Mr. V. Krishnakumar, Chief Operating Officer and Executive Director of the company. Thank you, and over to you, sir. Please go ahead.

Krishnakumar Vaidyanathan
Eris Lifesciences Ltd - Chief Operating Officer, Executive Director

Am I audible now?

Operator

Yes, sir. Please go ahead.

Krishnakumar Vaidyanathan
Eris Lifesciences Ltd - Chief Operating Officer, Executive Director

Wonderful. Welcome, everybody, to our quarter 3 conference call. As we get into today's conversation -- yes. So as we start today's conversation, we will start with recapping our journey since the public listing due date. So we had

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot